Skip to main content

WA42294 PRM-151: A PHASE III OPEN-LABEL EXTENSION STUDY TO EVALUATE LONG-TERM SAFETY AND EFFICACY OF PRM-151 IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF)

Clinical Trial Grant
Duke Scholars

Administered By

Medicine, Pulmonary, Allergy, and Critical Care Medicine

Awarded By

Genentech, Inc.

Start Date

March 16, 2022

End Date

March 15, 2027
 

Administered By

Medicine, Pulmonary, Allergy, and Critical Care Medicine

Awarded By

Genentech, Inc.

Start Date

March 16, 2022

End Date

March 15, 2027